GlideSheath Slender® Versus Conventional 5Fr Arterial Sheath in Coronary

Status Completed

Clinical Trial Summary

Transradial approach has become the default arterial access for coronary angiography (CAG) and percutaneous coronary intervention (PCI), mainly due to lower incidence of bleeding compared to transfemoral access.1 However, TRA is not deprived of local access site complications such as radial artery occlusion (RAO), occurring in approximately 5.2% of patients, compartment syndrome, pseudoaneurysm, hematoma, and arteriovenous fistula. Recently, a novel approach has been proposed, the access through the distal radial artery (distal transradial access, dTRA), located in the anatomical snuffbox. Initial studies regarding the dRA have shown feasibility and benefits, including shorter hemostasis time, fewer local access site complications and potentially lower incidence of RAO. GlideSheath Slender is a novel sheath which has a hydrophilic coating and is made of a thinner material than traditional sheaths. As a result, the external diameter of the 5 Fr GlideSheath Slender sheath is 1 Fr lower compared with conventional arterial sheaths. The purpose of the present study was to investigate whether the use of the Slender sheath affects the time of hemostasis, sheath insertion time, crossover rate to conventional radial access, pain associated with the procedure and incidence of local access site complications (RAO, distal radial artery occlusion, fistula, hematoma) in patients undergoing diagnostic angiography through the distal radial artery.

Clinical Trial Description

Patients fulfilling the enrollment criteria will be randomized 1:1 to GlideSheath Slender versus conventional 5Fr arterial sheath for access through the distal radial artery (dTRA). In case an interventional procedure is required then the initial sheath will be exchanged to a larger sheath according to the circumstances of the case and the patient will not be included in the analysis. For randomized patients sheath insertion time, necessity for crossover to conventional radial access, pain associated with the procedure (visual pain scale) and occurrence of hematoma will be recorded. Follow-up ultrasound 7-10 days after the procedure for detection of RAO, distal radial artery occlusion and fistula formation will be performed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04911218
Study type	Interventional
Source	University Hospital of Patras
Contact
Status	Completed
Phase	N/A
Start date	May 10, 2021
Completion date	December 2, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01239225` - Prevalence of Abdominal Aortic Aneurysm in Patients Undergoing Coronary Angiography	Phase 4
Recruiting	`NCT05075590` - Coronary Access After Supra-Annular THV Implantation	N/A
Completed	`NCT02606734` - DyeVert Pilot Trial	N/A
Completed	`NCT00632918` - Effects of Heart Rates and Variability of Heart Rates on Image Quality of Dual-Source CT Coronary Angiography	N/A
Completed	`NCT04801901` - Distal Transradial Access for Percutaneous Coronary Intervention	N/A
Completed	`NCT00345501` - Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention	Phase 2/Phase 3
Recruiting	`NCT04521660` - The Effect of Using Virtual Reality Glasses During Coronary Angiography	N/A
Completed	`NCT05982366` - Feasibility and Safety of the Routine Distal Transradial Approach	N/A
Recruiting	`NCT04982419` - Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial	Phase 2/Phase 3
Completed	`NCT00468195` - Optimizing Image Quality in Obese Patients Undergoing Coronary Computed Tomography (CT) Angiography	N/A
Completed	`NCT00468325` - Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT)	N/A
Recruiting	`NCT04318990` - DIstal vs Proximal Radial Artery Access for Cath	N/A
Recruiting	`NCT06312397` - The Effect on Back Pain and Fatigue Level of Acupressure	N/A
Recruiting	`NCT05319119` - Fractional Flow Reserve Derived From CT Related Treatment
Not yet recruiting	`NCT05133206` - Fasting or Non-fasting Before Cardiac Catheterization	N/A
Completed	`NCT02818101` - Hypnosis Efficacy for the Prevention of Anxiety During a Coronary Angiography	N/A
Completed	`NCT00465335` - Usefulness of Coronary CT Angiography in Patients With Inconclusive Stress Test Results	N/A
Recruiting	`NCT06035783` - Calcium Reduction by Orbital Atherectomy in Western Europe
Completed	`NCT04407936` - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention
Completed	`NCT05050877` - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

GlideSheath Slender® Versus Conventional 5Fr Arterial Sheath in Coronary Angiography Through the Distal Radial Artery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms